Upload
christopher-m
View
214
Download
1
Embed Size (px)
Citation preview
with OCA4 (The Human Gene Mutation
Database, HGMD 2013.1). However, this
Glycine 518 residue appears to be con-
served through all available vertebrate
genomes investigated, hence suggesting
a relevant functional role at this position,
plus it is true that other glycine-to-argi-
nine amino acid changes in the SLC45A2
protein have been already associated
with OCA4 (data from HGMD 2013.1:
p.G44R; p.G89R; p.G110R; p.G349R;
p.G370R; p.G404R). Some indirect evi-
dence of an altered association of the
mutant protein with membranes was
also reported by the authors. However, it
is probably expected, for a protein with
12 transmembrane domains, that it
would remain associated with mem-
branes, even in the presence of some
disruptive mutations, although these
minor topological alterations might actu-
ally result in a loss-of-function pheno-
type. The ultimate proof should be
provided by engineering this mutation in
an experimental animal model (i.e.
mouse or zebrafish) and/or, simply, by
reporting its presence in human subjects
diagnosed as OCA4.
Finally, the authors investigated the
landscape where this SLC45A2 muta-
tion was found in Snowflake’s genome
and showed that it is nicely located
within a large run (40 Mbps) of homo-
zygosity, orthologous to human chro-
mosome 5 (where the human
SLC45A2 gene is located), indicating
this allele was inside a block identical
by descent, characteristic for Mende-
lian recessive disorders. Furthermore,
by investigating the patterns of hetero-
zygosity in the Snowflake’s genome,
the authors inferred that it was likely a
result of inbreeding. Through computa-
tional simulations they concluded that
the most probable scenarios for Snow-
flake’s parents were uncle/niece or
aunt/nephew.
It is always rewarding to put an end
to previously unexplained observations,
especially if these refer to remarkable
individuals such this unique albino gor-
illa. Therefore, the authors of this
study must be praised for having com-
pleted the quest for the genetic cause
of the albinism of Snowflake. Person-
ally, as someone born in Barcelona
just 1 yr before Snowflake and some-
one that had the chance to witness
his life through my visits at the Zoo,
as many other visitors worldwide, it is
also good that the conservation plight
of Snowflake’s relatives has been
highlighted; let us hope that this is in
time to contribute to the efforts to
conserve these remarkable but endan-
gered primates.
References
Mart�ınez-Arias, R., Comas, D., Andr�es, A.,
Abell�o, M.T., Domingo-Roura, X., and
Bertranpetit, J. (2000). The tyrosinase
gene in gorillas and the albinism of
‘Snowflake’. Pigment Cell Res. 13, 467–70.
M�artinez-Garc�ıa, M., and Montoliu, L.
(2013). Albinism in Europe. J. Dermatol.
40, 319–24.Newton, J.M., Cohen-Barak, O., Hagiwara,
N., Gardner, J.M., Davisson, M.T., King,
R.A., and Brilliant, M.H. (2001). Muta-
tions in the human orthologue of the
mouse underwhite gene (uw) underlie a
new form of oculocutaneous albinism,
OCA4. Am. J. Hum. Genet. 69, 981–8.Regales, L., Giraldo, P., Garc�ıa-D�ıaz, A.,
Lavado, A., and Montoliu, L. (2003).
Identification and functional validation of
a 5′ upstream regulatory sequence in
the human tyrosinase gene homologous
to the locus control region of the mouse
tyrosinase gene. Pigment Cell Res. 16,
685–92.Roy, R., Cantero, M., and Montoliu, L.
(2004). Molecular and histological analysis
of the albinism of “Snowflake”. In: Pro-
gram and Abstracts of the 12th Meeting
of the European Society for Pigment Cell
Research. Pigment Cell Res. 17, 563–603.
Of white tigers and solute carriers
Alessandro Mongera and Christopher M. Dooleye-mail: [email protected]
The white tiger is a rare variant of the
Bengal tiger (Panthera tigris tigris) rep-
resenting a star attraction in many zoos
around the world. While the earliest
sightings in the jungles of the Indian
subcontinent were recorded in the
1500s, the last report of an individual
seen in the wild dates back to more
than fifty years ago: Indeed, the trade
of exotic animals, trophy hunting, and
habitat destruction have contributed to
heavily reducing the wild population. All
white tigers kept in captivity today are
likely descends of Mohan, a male white
tiger captured in 1951 in the former
State of Rewa, now part of the Repub-
lic of India. Moreover, in an attempt to
maintain the trait, they are highly
inbred, leading to inbreeding depres-
sion-related health problems.
White tigers lack pheomelanin (red-
to-yellow pigment) but have normal
eumelanin (brown-to-black pigment)
production. Vertical black/brown stripes
are formed normally while the orange
background is substituted by a light,
white fur. Furthermore, white tigers
have blue eyes, pink paw pads, and a
pink nose. The genetic basis of this vari-
ant, apart from the monogenetic auto-
somal recessive mode of inheritance,
has been enigmatic so far, although the
similarity with the chinchilla phenotype
in mice have suggested a possible
involvement of classical albino muta-
tions, such as those in the tyrosinase
(TYR) gene.
Xu et al. have recently reported that
the white tiger morph carries a genetic
lesion at a position reported to cause
OCA4 in humans, a form of oculocutane-
ous albinism. First, the authors excluded,
by direct sequencing, the mammalian
coat color modulators MC1R (melano-
cortin 1 receptor), ASIP (agouti-signaling
Coverage on: Xu, X., Dong, G.X., Hu,
X.S., Miao, L., Zhang, X.L., Zhang, D.L.,
Yang, H.D., Zhang, T.Y., Zou, Z.T.,
Zhang, T.T., Zhuang, Y., Bhak, J., Cho,
Y.S., Dai, W.T., Jiang, T.J., Xie, C.,
Li, R., Luo, S.J. (2013). The genetic
basis of white tigers. Curr. Biol. 23(11),
1031–5.
doi: 10.1111/pcmr.12163
ª 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 787
News and Views
peptide), TYR (tyrosinase), TYRP1 (tyro-
sine-related protein 1), and SLC7A11
(solute carrier family 7, member 11),
which fail to present any variation associ-
ated with the white tiger phenotype.
Next, using whole-genome sequencing
and restriction-site-associated DNA
sequencing within a known pedigree,
followed by validation in 130 unrelated
tigers by direct sequencing, they identi-
fied an alanine-to-valine substitution in
the solute carrier SLC45A2 as the causa-
tive mutation.
Mutations in SLC45A2, the mouse
underwhite gene (uw), have been linked
to a fourth class of human oculocutane-
ous albinism (OCA4) (Newton et al.,
2001), while the genes defective in the
other classes were already known. For
instance, OCA1 was known to be
associated with mutations in TYR, an
enzyme important for melanin produc-
tion; OCA2, the most common form of
OCA in Africa, with mutations in the
P gene, whose product regulates mela-
nosome pH through ion transport con-
trol; and OCA3, also known as ‘rufous/
red albinism’, with mutations in TYRP1,
encoding another enzyme involved in
pigment biosyn-
thesis.
Identifying the
mutation under-
lying the white
tiger morph rep-
resents an
important
achievement in
that it confirms
how modern
sequencing technology may be fruitfully
used in mapping allelic variants in non-
model organisms and it discloses the
genetic basis of the evocative appear-
ance of an animal that ‘has fascinated
humans for centuries ever since its dis-
covery in the jungles of India’. However,
it has to be acknowledged, as the
authors of this paper do, that genetic
lesions in SLC45A2 have already been
linked to color variation also in medaka
(Fukamachi et al., 2001), horse (Mariat
et al., 2003), chicken, and quail (Gun-
narsson et al., 2007). Recently, also the
Danio rerio albino mutant has been
shown to carry mutations in the coding
sequence of the same solute carrier
(Dooley et al., 2013).
Specifically, medaka fish homozygous
for b (a mutant allele of the gene
SLC45A2) represent a common orange-
red variant that has been bred in Japan
for hundreds of years. In these medaka
as well as in zebrafish albino mutants,
only melanophores are affected, while
the other pigment cell types (yellow
xanthophores, silver iridophores, and
white leukophores) appear normal (Doo-
ley et al., 2013; Fukamachi et al., 2001).
In horses, four ‘base’ colors, that is,
bay, black, brown, and chestnut, con-
tribute to the final coat coloration. Spo-
radically, some of these basic tones can
be diluted, only moderately as in buck-
skin or palomino horses, or strongly as
in cream horses, which have rosy skin,
blue eyes, and a coat that spans from
nearly white to rust-tinged. The ‘cream
mutation’ has been mapped to
SLC45A2 and is part of a set of causal
mutations responsible for coat color var-
iation so far described in horses, includ-
ing genetic lesions in MC1R (leading to
chestnut coat), EDNRB (leading to
white lethal), and ASIP and TYRP (lead-
ing to differential modulation of black
color)(Mariat et al., 2003).
Variation in plumage coloration in
chicken and Japanese quail is affected
by mutations in the Silver locus. Influ-
enced by numerous modifying genes,
these mutations cause a large range of
coat color modifications, but in general
lead to whitish plumage. By a candidate
gene approach, these mutations have
been mapped to the gene SLC45A2.
Interestingly, recessive null alleles
abolish almost completely both forms of
melanin, whereas dominant alleles
carrying missense mutation may
specifically affect only pheomelanin
(Gunnarsson et al., 2007). The pheno-
typic outcomes of these different
mutations, which can be similar in differ-
ent species, may find an explanation
once the exact role of the solute carrier
is fully clarified.
Since its cloning in mouse, SLC45A2
was proposed to function as osmotic
regulator. Sequence similarities with
membrane transporters such as sucrose/
proton symporters in plants and ultra-
structural studies of melanosomes in un-
derwhite mutants indeed suggested an
involvement of this protein in pH control.
Notably, the identity of the substance
transported through the melanosome
membrane remains unclear; cysteine,
necessary for pheomelanin production,
and sugars, cotransported with protons,
are privileged candidates.
Interestingly, Xu et al. argue that the
white tiger variant is a fully viable natural
genetic polymorphism. They reason
that, as mature white tigers have been
spotted or captured in the past, this
character may not affect the overall fit-
ness, excluding the possibility to classify
it as a genetic deformity. It is important
to note that survival to adulthood does
not represent the only parameter to take
in account in the estimation of fitness;
in fact, the defining characteristic of
OCA is the adverse effects of hypopig-
mentation on the visual system which,
although functionally impaired, is still
compatible with adult life (as shown in
numerous species, including humans).
Moreover, it is not clear that natural
genetic polymorphism and disease
(genetic deformity) are necessarily non-
overlapping categories.
Examples of natural color variation
have been recently reported to act
through Kit signaling in stickleback and
agouti in deer mice. It is interesting to
note that the number of reported cases
of natural variation in the key melanin
producing enzyme tyrosinase (Tyr) is
limited, also in humans. Could this be
an indication of an evolutionary con-
straint where less viable variants arise
from mutations in TYR as opposed to
other genes typically identified to be
involved in color variation, for example
SLC45A2, or are the examples still to
be found?
In this regard, zebrafish may offer
some new insights. A recent study on
zebrafish albino has provided evidence
of the involvement of Slc45a2 in melan-
osomal pH homeostasis (Dooley et al.,
2013). First, expression analysis indi-
cates an autonomous role of the pro-
tein within the melanocyte lineage;
second, chemical treatments demon-
strate a role of Slc45a2 in regulating
the normal enzymatic activity of tyrosi-
nase through modulation of proton
exchange, within a molecular axis that
comprises also the organelle acidifier
V-ATPase complex and the potassium-
dependent sodium/calcium exchanger
Slc24a5. Interestingly, ultrastructural
analysis of melanosome biogenesis in
Tyr null mutants reveals a catastrophic
breakdown of melanosomes and toxic-
ity in neighboring cells, whereas various
alleles of slc45a2 simply lead to modu-
lation of melanin content but do not
seem to affect the biochemistry out-
side melanosomes. This could explain
the multiple examples previously
reported in the association of SLC45A2
and color variation among the animal
kingdom.
As we continue to sequence an ever-
greater number of species and variants,
it will be exciting to see what other solu-
tions evolution has come up with to
modify traits and features of our natural
world.
“modernsequencingtechnology maybe fruitfully usedin mappingallelic variants innon-modelorganisms”
788 ª 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
News and Views
References
Dooley, C.M., Schwarz, H., Mueller, K.P.,
Mongera, A., Konantz, M., Neuhauss,
S.C., N€usslein-Volhard, C., and Geisler,
R. (2013). Slc45a2 and V-ATPase are
regulators of melanosomal pH homeo-
stasis in zebrafish, providing a mecha-
nism for human pigment evolution and
disease. Pigment Cell Melanoma Res.
26, 205–217.
Fukamachi, S., Shimada, A., and Shima, A.
(2001). Mutations in the gene encoding B,
a novel transporter protein, reduce mela-
nin content in medaka. Nat. Genet. 28,
381–385.Gunnarsson, U., Hellstr€om, A.R., Tixier-
Boichard, M., Minvielle, F., Bed’hom,
B., Ito, S., Jensen, P., Rattink, A., Vereij-
ken, A., and Andersson, L. (2007). Muta-
tions in SLC45A2 cause plumage color
variation in chicken and Japanese quail.
Genetics 175, 867–877.
Mariat, D., Taourit, S., and Guerin, G.
(2003). A mutation in the MATP gene
causes the cream coat colour in the
horse. Genet. Sel. Evol. 35, 119–133.Newton, J.M., Cohen-Barak, O., Hagiwara,
N., Gardner, J.M., Davisson, M.T., King,
R.A., and Brilliant, M.H. (2001). Muta-
tions in the human orthologue of the
mouse underwhite gene (uw) underlie a
new form of oculocutaneous albinism,
OCA4. Am. J. Hum. Genet. 69, 981–988.
Three BRNs are better than two
Colin R. Goding
e-mail: [email protected]
Melanoma proliferation is driven by
mutations that activate drivers of the
mitogen-activated kinase (MAPK) path-
way such as NRAS or BRAF. These
mutations occur frequently, but only
rarely go on to progress to full-blown
melanoma. This is because cells faced
with overactive MAPK signalling acti-
vate pro-senescence mechanisms lead-
ing to a largely irreversible cell cycle
arrest as is found in benign nevi.
Only when senescence bypass is
achieved, will cells with MAPK path-
way activating mutations proliferate
indefinitely.
In general, oncogene-induced senes-
cence (OIS) requires both the p53 and
Rb1 pathways to be intact and as such
can be bypassed via many routes.
These include mutation or epigenetic
inactivation of CDKN2A (p16INK4a), over-
expression of cyclin D or b-catenin and
elevated expression of the T-box factors
TBX2 or TBX3. In animal models and in
cell culture, loss of PTEN leading to
constitutive activation of PI3K signalling
also bypasses OIS, while depletion of
the so-called master regulator of the
melanocyte lineage, the microphthalmia-
associated transcription factor (MITF),
promotes senescence.
In the paper from Hohenauer et al., a
new melanoma antisenescence factor is
revealed: BRN3a, a member of the POU
domain transcription factor family that
includes the melanoma-associated tran-
scription factor BRN2 and the pluripo-
tency factor OCT4. BRN3a is required
for the development of neurosecretory
neurons and of endocrine tissues, as
well as the development of subtypes
of sensory neurons. Consistent with its
developmental role, in adults, its
expression appears to be restricted to
subsets of neuronal cells and testis.
However, expression in the melano-
cyte lineage in general and in mela-
noma in particular has not previously
been described.
Hohenauer et al. first show that
BRN3a mRNA is overexpressed in
around 75% of melanoma cell lines
compared with melanocytes, fibroblasts
or keratinocytes, but is not associated
with any particular stage of disease pro-
gression, and examination of tumour
sections revealed a staining pattern
with a variable intensity of either
homogenous or heterogeneous expres-
sion. By using siRNA to deplete BRN3a,
the authors also showed that BRN3a
was important for tumour growth
in vivo in nude mice, with diminished
BRN3a expression leading to a slow-
growth phenotype. The pro-proliferative
effect of BRN3a on melanoma prolifera-
tion in vivo was consistent with results
obtained using cell lines, in which
decreasing BRN3a expression led to
loss of S-phase and, at later times,
increased apoptosis most likely because
BRN3a is a positive regulator of the
anti-apoptotic gene BCL2 (Budhram-
Mahadeo et al., 1999). The cause of
the G1 arrest on BRN3a-depletion
appears to be via the induction of DNA
double-strand breaks, indicated by the
presence of cH2AX foci and consequent
up-regulation of p53 and its target
CDKN1A (p21), a cyclin-dependent
kinase inhibitor. Significantly, lentiviral-
driven ectopic expression of BRN3a in
primary human melanocytes led to
anchorage-independent growth, and
BRN3a could cooperate with BRAFV600E
to transform primary melanocytes, indi-
cating that BRN3a was able to suppress
OIS.
Taken together the data presented
suggest that overexpression of BRN3a
represents a powerful pro-oncogenic
factor. As always, however, the results
lead to several issues that no doubt will
be addressed in the near future. These
include what regulates BRN3a expres-
sion and activity in melanomas, and
when and where it might be expressed
in the melanocyte lineage in develop-
ment and in adults as might be
expected for a factor expressed in
melanoma. But perhaps the most
obvious question is whether BRN3a,
like its close relative BRN2 (Goodall
et al., 2008), represses MITF expres-
sion. Many if not all of the phenotypes
observed would be accounted for if
BRN3a were able to regulate MITF,
because reduced levels of MITF are
known to cooperate with BRAFV600E in
fish melanoma models (Lister et al.,
2013), and changing MITF levels also
leads to alterations in senescence
(Giuliano et al., 2010), and proliferative
Coverage on: Hohenauer et al. (2013).
The neural crest transcription factor
Brn3a is expressed in melanoma and
required for cell cycle progression and
survival. EMBO Mol. Med. 5, 919–934.
doi: 10.1111/pcmr.12150
ª 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 789
News and Views